Clinical Trial Update: Rituximab in the Treatment of Idiopathic Membranous Nephropathy [EARLY_Phase 1]

View source ↗

Summary

This document reports on an early-phase Phase 1 clinical trial evaluating rituximab for idiopathic membranous nephropathy, with the study status listed as compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Membranous Nephropathy

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Membranous Nephropathy | EARLY_Phase 1 | Status: COMPLETED